Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01123577 · ClinicalTrials.gov registry record · NA

Evaluation of Integrating Self Blood Pressure Monitoring Into Urban Primary Care Practices

A NA study, sponsored by New York City Department of Health and Mental Hygiene.

Completed
Registry status
NA
Development phase
899
Enrollment target

NCT01123577: Completed NA study, sponsored by New York City Department of Health and Mental Hygiene.

NCT01123577 is a NA study that has completed, run by New York City Department of Health and Mental Hygiene. The registered enrollment target is 899 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01123577, a NA study, has completed, sponsored by New York City Department of Health and Mental Hygiene.

COMPLETED
Registry status
NA
Development phase
899 participants
Enrollment target

Study Summary

Background: Hypertension (HTN) is a major risk factor for cardiovascular disease (CVD), the leading cause of death in the United States and New York City (NYC). One in 4 NYC adults has hypertension, with higher prevalence in both Blacks and Latinos compared to Whites (Angell 2008). In NYC, only 65% of all adults with HTN and on treatment are controlled (Angell 2008). Self-blood pressure monitoring (SBPM) is associated with reduced blood pressure in patients with hypertension (Cappuccio 2004). Studies suggest that SBPM may increase control either by inducing clinicians to titrate medication more actively, (Agency for Healthcare Research and Quality 2002) by engaging patients to participate in their own health care, (Taylor 2007) or a combination of the two. However, minimal research has been done to evaluate the effectiveness of SBPM in different racial and/or ethnic groups or in low income populations or to discern effective patterns of SBPM use by patients. Best practices for integration of self monitoring into HTN into regular treatment have also yet to be established. Objectives: The goal of this study is to assess the impact of SBPM under conditions consistent with existing community health clinic resources and infrastructure in NYC's medically underserved neighborhoods using commonly available automated home BP monitors. By using a community clinic's electronic health record (EHR) and automated BP monitors with the capability to transmit readings to a research database, we can facilitate a more rigorous evaluation of a pilot SBPM intervention and assess patterns of home monitor use and clinical management and their association with outcomes. The three specific aims of this intervention are to: 1. Assess whether use of SBPM reduces elevated BP and increases HTN control to similar levels in two historically understudied minority populations, Blacks and Latinos. 2. Confirm pilot findings by assessing the impact of SBPM on BP and HTN control compared to usua

Interventions

  • OTHER Home Blood Pressure Monitor Group

Trial Details

FieldValue
Enrollment Target 899 participants
Start Date 2010-05
Est. Completion 2012-08
Phase NA

What the finished NCT01123577 record still lists

NCT01123577 is an interventional study that assigns participants to a tested intervention. The registered 899 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower).

The record links to 0 conditions, and to 1 intervention - of which Home Blood Pressure Monitor Group is the first listed.

NCT01123577 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01123577 about?

NCT01123577 is a clinical study titled "Evaluation of Integrating Self Blood Pressure Monitoring Into Urban Primary Care Practices". Background: Hypertension (HTN) is a major risk factor for cardiovascular disease (CVD), the leading cause of death in the United States and New York City (NYC). One in 4 NYC adults has hypertension, with higher prevalence in both Blacks and Latinos compared to Whites (Angell 2008). In NYC, only 65%...

What is the current status of trial NCT01123577?

This trial is currently completed. It is a NA study. The enrollment target is 899 participants. The study started on 2010-05. Estimated completion is 2012-08.

What interventions are being tested in trial NCT01123577?

The interventions under investigation include: Home Blood Pressure Monitor Group (OTHER).

Who is sponsoring clinical trial NCT01123577?

This trial is sponsored by New York City Department of Health and Mental Hygiene, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01123577's enrollment target sits among peer trials

899 130th of 2000 higher than 1,871 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01123577, the US trial registry maintained by the National Library of Medicine. NCT01123577 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.